Citation Impact
Citing Papers
Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment
2010
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
2018
Using the Transcription Factor Inhibitor of DNA Binding 1 to Selectively Target Endothelial Progenitor Cells Offers Novel Strategies to Inhibit Tumor Angiogenesis and Growth
2010
LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
2013
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
2019
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
TGF-β-Id1 Signaling Opposes Twist1 and Promotes Metastatic Colonization via a Mesenchymal-to-Epithelial Transition
2013
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Targeting hypoxia in cancer therapy
2011 Standout
MYC on the Path to Cancer
2012 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Cancer to bone: a fatal attraction
2011 Standout
R1 Resection by Necessity for Colorectal Liver Metastases
2008
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter
2019
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
2008
JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma
2011
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors
2011
Lung cancer: current therapies and new targeted treatments
2016 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Antibody therapy of cancer
2012 Standout
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
2019
p21 in cancer: intricate networks and multiple activities
2009 Standout
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
2015
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer
2015 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
EMT: 2016
2016 Standout
TGFβ in Cancer
2008 Standout
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells
2009
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
Therapeutic Targeting of Myc
2010
Metastatic colonization by circulating tumour cells
2016 StandoutNature
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
RECIST revisited: A review of validation studies on tumour assessment
2006
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
2010
Quantifying critical states of complex diseases using single-sample dynamic network biomarkers
2017
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
ID genes mediate tumor reinitiation during breast cancer lung metastasis
2007
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
2021
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
2010
Tissue Factor Pathway Inhibitor and P-Selectin as Markers of Sepsis-Induced Non-overt Disseminated Intravascular Coagulopathy
2009
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Polyomavirus microRNAs circulating in biological fluids during viral persistence
2017
Works of Ignacio Gil‐Bazo being referenced
TGFBI expression is associated with a better response to chemotherapy in NSCLC
2010
Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
2009
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
2014
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis
2008
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
2018
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
2015
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
2018
Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
2002
Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab
2009
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients
2013
Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice
2015
Targeting hypoxia and angiogenesis through HIF-1alpha inhibition
2005
Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?
2005
Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer
2004
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
2016
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.
2014
Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer
2005
Reassessment of Id1 Protein Expression in Human Mammary, Prostate, and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Id1 Antibody
2006